Peripheral Neuropathic Pain

Neurology

9 drugs in development·7 companies·0 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
Cymbalta®	ELI LILLY & Co (LLY)
duloxetine	Inventiva S.A. (IVA)

Phase 2(5)

Drug	Company
cemdomespib	REATA PHARMACEUTICALS INC (RETA)
LY4065967	ELI LILLY & Co (LLY)
pilavapadin	LEXICON PHARMACEUTICALS, INC. (LXRX)
rta 901	BIOGEN INC. (BIIB)
rta 901	REATA PHARMACEUTICALS INC (RETA)

Phase 1(1)

Drug	Company
vx-993	VERTEX PHARMACEUTICALS INC / MA (VRTX)

Phase 4(1)

Drug	Company
IncobotulinumtoxinA	Revance Therapeutics, Inc. (RVNC)

Full trial data, competitive analysis, and AI-powered pipeline tracking.